Response Biomedical Corp (RBM) Financial Statements (2024 and earlier)

Company Profile

Business Address 1781 - 75TH AVENUE W.
VANCOUVER, BC V6P6P2
State of Incorp. BC
Fiscal Year End December 31
Industry (SIC) 8734 - Testing Laboratories (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2016
MRQ
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 2,5113,2212,9582,080
Cash and cash equivalents 2,5113,2212,9582,080
Receivables 5667918751,483
Inventory, net of allowances, customer advances and progress billings 1,8192,0562,2501,791
Inventory 1,8192,0562,2501,791
Deferred costs 908873 
Prepaid expense and other current assets211
Other undisclosed current assets 134183235188
Total current assets: 5,1206,3396,3915,752
Noncurrent Assets
Property, plant and equipment 5,6896,2506,8197,602
Prepaid expense 939393
Restricted cash and investments 901901901901
Deferred costs 345  
Prepaid expense and other noncurrent assets93
Total noncurrent assets: 6,6867,2897,8138,595
TOTAL ASSETS: 11,80613,62814,20414,348
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 3,4664,0362,7271,897
Accounts payable 3,2973,8672,7271,897
Accrued liabilities 169169  
Debt 868546413370
Derivative instruments and hedges, liabilities 3011,2495,2513,700
Deferred revenue and credits 1,31187162255
Other undisclosed current liabilities 489409170173
Total current liabilities: 6,4357,1118,6236,394
Noncurrent Liabilities
Long-term debt and lease obligation, including: 4,6945,2085,6696,082
Long-term debt, excluding current maturities 3601,0045,6696,082
Other undisclosed long-term debt and lease obligation 4,3344,204  
Liabilities, other than long-term debt  22816
Deferred revenue and credits  22816
Other undisclosed noncurrent liabilities 1,3882,2011,3661,535
Total noncurrent liabilities: 6,0827,4117,0637,633
Total liabilities: 12,51714,52215,68614,027
Equity
Equity, attributable to parent (711)(894)(1,482)321
Common stock 104,314104,124101,94599,289
Additional paid in capital 15,38415,24114,74213,203
Accumulated deficit (120,409)(120,259)(118,169)(112,171)
Total equity: (711)(894)(1,482)321
TOTAL LIABILITIES AND EQUITY: 11,80613,62814,20414,348

Income Statement (P&L) ($ in thousands)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
 15,41811,01411,5314,246
Cost of revenue
(Cost of Goods and Services Sold)
 (7,339)(6,932)(6,613)(7,721)
Other undisclosed gross profit  285257,721
Gross profit: 8,0794,3674,9434,246
Operating expenses (7,794)(9,400)(8,147)(8,449)
Other operating expense, net   (2,794)(1,079)
Operating income (loss): 285(5,033)(5,998)(5,281)
Nonoperating income (expense) (435)6,8282,17119
Investment income, nonoperating 9584,0172,12922
Loss, foreign currency transaction, before tax (472)(132)(16)(2)
Other nonoperating income (expense) (43)2,94358 
Interest and debt expense (878)(874)(696)(734)
Income (loss) from continuing operations before income taxes: (1,028)921(4,523)(5,995)
Income tax expense  (68)(41) 
Income (loss) from continuing operations: (1,028)853(4,564)(5,995)
Income (loss) before gain (loss) on sale of properties: (1,028)853(4,564)(5,995)
Net income (loss): (1,028)853(4,564)(5,995)
Other undisclosed net income (loss) attributable to parent 878(2,943)(1,434)714
Net loss available to common stockholders, diluted: (150)(2,090)(5,998)(5,281)

Comprehensive Income ($ in thousands)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss): (1,028)853(4,564)(5,995)
Comprehensive income (loss), net of tax, attributable to parent: (1,028)853(4,564)(5,995)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: